Your session is about to expire
← Back to Search
Digital Hypertension Management System
Digital Hypertension Management for High Blood Pressure (HrtEx Trial)
N/A
Recruiting
Led By Paul J Wang, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≤ 2 current anti-HTN meds
Age 30-90 yrs.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1 (baseline), visit-3 (6 month follow up)
Awards & highlights
HrtEx Trial Summary
This trial compares two treatments to see which is more effective. Results are analyzed from two groups of people.
Who is the study for?
This trial is for adults aged 30-90 with high blood pressure who own a smartphone and are currently on no more than two blood pressure medications. They must be able to increase the dosage or add at least two types of certain blood pressure drugs, and speak English or Spanish. People can't join if they're pregnant, have specific heart or kidney conditions, recently had a heart attack or stroke, were hospitalized for severe hypertension, or had an organ transplant.Check my eligibility
What is being tested?
The study compares a digital system that helps manage high blood pressure against the usual care methods. Participants will be randomly assigned to one of these two groups in this parallel-design trial to see which is more effective at controlling their condition.See study design
What are the potential side effects?
Since this trial involves standard hypertension treatments compared with digital management tools rather than new medications, side effects may not apply as typically seen in drug trials but could include issues related to medication adjustments.
HrtEx Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am taking 2 or fewer medications for high blood pressure.
Select...
I am between 30 and 90 years old.
HrtEx Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ visit-1 (baseline), visit-3 (6 month follow up)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit-1 (baseline), visit-3 (6 month follow up)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Defined Daily Dose (DDD)
Secondary outcome measures
Antihypertensive Drugs
Clinician inertia
Diastolic blood pressure (DBP)
+2 moreHrtEx Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Health TechnologyExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,150 Total Patients Enrolled
Santa Clara Valley Medical CenterOTHER
16 Previous Clinical Trials
2,190 Total Patients Enrolled
The Cooper Health SystemOTHER
76 Previous Clinical Trials
32,913 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am taking 2 or fewer medications for high blood pressure.I have not had a heart attack or stroke in the last 6 months.My heart's pumping ability is significantly reduced.I have had a solid organ transplant.I am between 30 and 90 years old.I am on dialysis.I speak English or Spanish.My kidneys are failing (GFR <15).I was hospitalized for a severe hypertension crisis in the last 6 months.I can start or increase the dose of at least 2 types of heart medications.Your blood pressure at the doctor's office is 140 mm Hg or higher.You own a smartphone.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Mobile Health Technology
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is eligibility for this trial restricted to those over 45 years of age?
"Those who wish to participate in this research must be at least 30 years old and younger than 90."
Answered by AI
Is there an ongoing call for volunteers to participate in this research?
"Affirmative. Clinicaltrials.gov confirms that this medical trial, which was initially published on June 13th 2023, is presently recruiting participants for its research. 200 patients must be sourced from 1 clinical centre."
Answered by AI
What demographics are eligible to partake in this research?
"The criteria for enrolment in this clinical trial requires that potential candidates have high blood pressure and be between 30-90 years of age. Approximately 200 patients will take part."
Answered by AI
What is the capacity of participants in this medical research endeavor?
"Affirmative. The information provided on clinicaltrials.gov attests to this trial's current status of actively recruiting participants. Initially established on June 13th, 2023 and later updated August 27th, 2023, the study aims to enrol 200 individuals at 1 medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger